E. Tavşan Et Al. , "Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. ," 6th International Conference Cancer Immunotherapy and Immunomonitoring. , Tbilisi, Georgia, 2019
Tavşan, E. Et Al. 2019. Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. . 6th International Conference Cancer Immunotherapy and Immunomonitoring. , (Tbilisi, Georgia).
Tavşan, E., Yıldız, A. S., & Erin, N., (2019). Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. . 6th International Conference Cancer Immunotherapy and Immunomonitoring. , Tbilisi, Georgia
Tavşan, ESRA, Ayşe Sevgi Yıldız, And NURAY ERİN. "Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. ," 6th International Conference Cancer Immunotherapy and Immunomonitoring. , Tbilisi, Georgia, 2019
Tavşan, ESRA Et Al. "Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. ." 6th International Conference Cancer Immunotherapy and Immunomonitoring. , Tbilisi, Georgia, 2019
Tavşan, E. Yıldız, A. S. And Erin, N. (2019) . "Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. ." 6th International Conference Cancer Immunotherapy and Immunomonitoring. , Tbilisi, Georgia.
@conferencepaper{conferencepaper, author={ESRA TAVŞAN Et Al. }, title={Inhibition of PI3Kα activity decreases chemokine release and enhances anti-proliferative effects of PEG-DOX in metastatic breast cancer. }, congress name={6th International Conference Cancer Immunotherapy and Immunomonitoring. }, city={Tbilisi}, country={Georgia}, year={2019}}